- $491.19m
- $823.53m
- $1.10bn
- 90
- 71
- 62
- 87
Annual income statement for PetIQ, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 709 | 780 | 933 | 922 | 1,102 |
| Cost of Revenue | |||||
| Gross Profit | 107 | 135 | 186 | 210 | 253 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 713 | 783 | 922 | 942 | 1,065 |
| Operating Profit | -3.14 | -3.19 | 10.4 | -20.2 | 37.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -17.6 | -25.3 | -12.5 | -47.4 | 2.37 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -14.3 | -85.7 | -16.4 | -48.6 | 2.54 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -11.5 | -82.7 | -16 | -48.2 | 2.13 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -11.5 | -82.7 | -16 | -48.2 | 2.13 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.183 | -2.83 | -0.111 | -0.455 | 0.577 |